Home
/ Lyell
/ Competitors

Lyell Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Jounce Therapeutics, Arvinas and NovoCure.

	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	Jounce Therapeutics Jounce Therapeutics is a clinical-stage immunotherapy company.	Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Founding Date	Founding Date 2018	Founding Date 2013	Founding Date N/A	Founding Date 2000
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech oncology platform therapy	Tags Healthcare Technology healthtech oncology platform therapy	Tags Healthcare Technology drug development oncology pharma platform therapy	Tags Healthcare biotech medical devices oncology platform therapy
Locations	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations Cambridge, US HQ	Locations New Haven, US HQ	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more
Employees	Employees 188	Employees 1302% increase	Employees 13329% increase	Employees 1,488
Valuation ($)	Valuation ($) 243.3 m	Valuation ($) 101.6 m	Valuation ($) 1.9 b	Valuation ($) 1.8 b
Financial
Revenue (est.)	Revenue (est.) $36k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $262.6m (FY, 2025)	Revenue (est.) $655.4m (FY, 2025)
Net income	Net income ($274.4m) (FY, 2025)	Net income ($50.9m) (FY, 2022)	Net income ($80.8m) (FY, 2025)	Net income ($136.2m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 103m	Total funding raised $ 111.6m	Total funding raised N/A